Issued Patents All Time
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12053468 | Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereof | Simon Stewart Jones, Teru Hideshima, Kenneth C. Anderson | 2024-08-06 |
| 11998546 | Pharmaceutical combinations comprising a histone deacetylase inhibitor and epothilone and methods of use thereof | Pengyu Huang | 2024-06-04 |
| 11872227 | Pharmaceutical combinations comprising a histone deacetylase inhibitor and an aurora kinase inhibitor and methods of use thereof | Brian North | 2024-01-16 |
| 11813261 | HDAC inhibitors, alone or in combination with BTK inhibitors, for treating chronic lymphocytic leukemia | Simon Stewart Jones, Eva Sahakian, Javier Pinilla Ibarz | 2023-11-14 |
| 11497746 | Pharmaceutical combinations comprising a histone deacetylase inhibitor and a programmed death-ligand 1 (PD-L1) inhibitor and methods of use thereof | Simon Stewart Jones, Teru Hideshima, Kenneth C. Anderson | 2022-11-15 |
| 11357776 | Pharmaceutical combinations comprising a histone deacetylase inhibitor and an aurora kinase inhibitor and methods of use thereof | Brian North | 2022-06-14 |
| 11337975 | Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereof | Simon Stewart Jones, Teru Hideshima, Kenneth C. Anderson | 2022-05-24 |
| 11324744 | Methods of use and pharmaceutical combinations of histone deacetylase inhibitors and CD20 inhibitory antibodies | Simon Jones, Chengyin Min | 2022-05-10 |
| 11311540 | Increasing expression of interferon regulated genes with combinations of histone deacetylase inhibitors and immunomodulatory drugs | Jeffrey R. Shearstone | 2022-04-26 |
| 11298354 | Methods of use and pharmaceutical combinations of HDAC inhibitors with BET inhibitors | Kwok-Kin Wong, Yan Liu, Dennis O. Adeegbe | 2022-04-12 |
| 9949972 | Combinations of histone deacetylase inhibitors and immunomodulatory drugs | Simon Stewart Jones | 2018-04-24 |